These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Pathophysiology, diagnosis, and treatment of gastrointestinal stromal tumors. Shinomura Y; Kinoshita K; Tsutsui S; Hirota S J Gastroenterol; 2005 Aug; 40(8):775-80. PubMed ID: 16143881 [TBL] [Abstract][Full Text] [Related]
15. microRNA expression signatures of gastrointestinal stromal tumours: associations with imatinib resistance and patient outcome. Akçakaya P; Caramuta S; Åhlen J; Ghaderi M; Berglund E; Östman A; Bränström R; Larsson C; Lui WO Br J Cancer; 2014 Nov; 111(11):2091-102. PubMed ID: 25349971 [TBL] [Abstract][Full Text] [Related]
16. [The importance of mutational status in prognosis and therapy of GIST]. Comandone A; Boglione A Recenti Prog Med; 2015 Jan; 106(1):17-22. PubMed ID: 25621775 [TBL] [Abstract][Full Text] [Related]
18. Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expression. Tang CM; Lee TE; Syed SA; Burgoyne AM; Leonard SY; Gao F; Chan JC; Shi E; Chmielecki J; Morosini D; Wang K; Ross JS; Kendrick ML; Bardsley MR; Siena M; Mao J; Harismendy O; Ordog T; Sicklick JK Oncotarget; 2016 Nov; 7(48):78226-78241. PubMed ID: 27793025 [TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal stromal tumors: key to diagnosis and choice of therapy. Rutkowski P; Debiec-Rychter M; Ruka W Mol Diagn Ther; 2008; 12(3):131-43. PubMed ID: 18510377 [TBL] [Abstract][Full Text] [Related]